Insider · CIK 0001489966

Morris Charles Q

Reports to the SEC for 5 companies · WILMINGTON, DE

sec.gov

Transactions

Companies

Filings

CIK

0001489966

Forms 4 and 5

Insider transactions

39 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-01	PRLDPrelude Therapeutics Inc · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+450K sh	$4.70	+$2.12M	450,000
2025-02-13	LAVA Therapeutics NVShare Options (Right to Buy)A Award	Chief Medical Officer	AAward	+131K sh	—	—	130,850
2020-02-26	Radius Health, Inc.S Sale	Chief Medical Officer	SSale	−1,256 sh	$17.93	−$22.5K	33,744
2020-02-20	Radius Health, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+30K sh	—	—	30,000
2020-02-20	Radius Health, Inc.A Award	Chief Medical Officer	AAward	+20K sh	—	—	35,000
2019-02-22	Radius Health, Inc.A Award	Chief Medical Officer	AAward	+15K sh	—	—	15,000
2019-02-22	Radius Health, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+55K sh	—	—	55,000
2018-09-04	Radius Health, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+130K sh	—	—	130,000
2016-07-18	ImmunoGen, Inc.Stock option (right to buy)A Award	Executive VP & CDO	AAward	+110K sh	$3.05	+$336K	110,000
2015-11-27	ImmunoGen, Inc.S Sale	Executive VP & CDO	SSale	−5,170 sh	$14.00	−$72.4K	27,090
2015-07-13	ImmunoGen, Inc.Stock option (right to buy)A Award	Executive VP & CDO	AAward	+110K sh	$16.72	+$1.84M	110,000
2014-11-28	ImmunoGen, Inc.S Sale	Executive VP & CDO	SSale	−5,240 sh	$10.40	−$54.5K	32,260
2014-07-17	ImmunoGen, Inc.Stock option (right to buy)A Award	Executive VP & CDO	AAward	+110K sh	$10.79	+$1.19M	110,000
2014-02-26	ImmunoGen, Inc.S Sale	Executive VP & CDO	SSale	−6,936 sh	$17.35	−$120K	37,500
2014-02-26	ImmunoGen, Inc.M Exercise/Conversion	Executive VP & CDO	MExercise/Conversion	+6,936 sh	$11.93	+$82.7K	44,436
2014-02-26	ImmunoGen, Inc.Stock Option (right to buy)M Exercise/Conversion	Executive VP & CDO	MExercise/Conversion	−6,936 sh	$11.93	−$82.7K	172,254
2014-02-20	ImmunoGen, Inc.M Exercise/Conversion	Executive VP & CDO	MExercise/Conversion	+13.7K sh	$11.93	+$163K	51,172
2014-02-20	ImmunoGen, Inc.S Sale	Executive VP & CDO	SSale	−13.7K sh	$17.10	−$234K	37,500
2014-02-20	ImmunoGen, Inc.Stock Option (right to buy)M Exercise/Conversion	Executive VP & CDO	MExercise/Conversion	−13.7K sh	$11.93	−$163K	179,190
2014-01-22	ImmunoGen, Inc.M Exercise/Conversion	Executive VP & CDO	MExercise/Conversion	+1,603 sh	$11.93	+$19.1K	39,103
2014-01-22	ImmunoGen, Inc.Stock Option (right to buy)M Exercise/Conversion	Executive VP & CDO	MExercise/Conversion	−1,603 sh	$11.93	−$19.1K	192,862
2014-01-22	ImmunoGen, Inc.S Sale	Executive VP & CDO	SSale	−1,603 sh	$17.00	−$27.3K	37,500
2014-01-21	ImmunoGen, Inc.Stock Option (right to buy)M Exercise/Conversion	Executive VP & CDO	MExercise/Conversion	−5,535 sh	$11.93	−$66K	194,465
2014-01-21	ImmunoGen, Inc.S Sale	Executive VP & CDO	SSale	−5,535 sh	$17.00	−$94.1K	37,500
2014-01-21	ImmunoGen, Inc.M Exercise/Conversion	Executive VP & CDO	MExercise/Conversion	+5,535 sh	$11.93	+$66K	43,035
2013-11-26	ImmunoGen, Inc.S Sale	Executive VP & CDO	SSale	−12.5K sh	$13.75	−$172K	37,500
2013-07-16	ImmunoGen, Inc.Stock option (right to buy)A Award	Executive VP & CDO	AAward	+58.3K sh	$19.02	+$1.11M	58,333
2012-09-04	ALLOS THERAPEUTICS INCU Disposition from Tender	Chief Medical Officer	UDisposition from Tender	−655K sh	$1.82	−$1.19M	0
2012-04-27	ALLOS THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−7,970 sh	$1.81	−$14.4K	655,031
2012-04-27	ALLOS THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−7,970 sh	$1.81	−$14.4K	665,323
2012-03-01	ALLOS THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−10.3K sh	$1.48	−$15.2K	663,001
2012-02-29	ALLOS THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−10.2K sh	$1.52	−$15.5K	673,293
2012-02-29	ALLOS THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−10.2K sh	$1.52	−$15.5K	673,293
2012-02-28	ALLOS THERAPEUTICS INCA Award	Chief Medical Officer	AAward	+242K sh	—	—	683,448
2012-02-28	ALLOS THERAPEUTICS INCA Award	Chief Medical Officer	AAward	+242K sh	—	—	683,448
2011-11-15	ALLOS THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−17.8K sh	$1.44	−$25.7K	441,600
2011-04-27	ALLOS THERAPEUTICS INCS Sale	Chief Medical Officer	SSale	−9,800 sh	$2.84	−$27.8K	459,429
2011-02-28	ALLOS THERAPEUTICS INCA Award	Chief Medical Officer	AAward	+186K sh	—	—	469,229
2010-10-20	ALLOS THERAPEUTICS INCA Award	Chief Medical Officer	AAward	+173K sh	—	—	283,378

Recent filings

Accepted (ET)
May 44
Morris Charles Q0001489966-26-000004
SEC(opens sec.gov)
Feb 184
Morris Charles Q0001415889-25-004525
SEC(opens sec.gov)
Feb 284
Morris Charles Q0001209191-20-013793
SEC(opens sec.gov)
Feb 244
Morris Charles Q0001209191-20-012155
SEC(opens sec.gov)
Feb 264
Morris Charles Q0001209191-19-013718
SEC(opens sec.gov)
Sep 54
Morris Charles Q0001209191-18-049624
SEC(opens sec.gov)
Jul 204
IMMUNOGEN INC0001179110-16-027766
SEC(opens sec.gov)
Nov 304
IMMUNOGEN INC0001179110-15-015508
SEC(opens sec.gov)
Jul 144
IMMUNOGEN INC0001179110-15-011171
SEC(opens sec.gov)
Dec 24
IMMUNOGEN INC0001179110-14-017314
SEC(opens sec.gov)
Jul 184
IMMUNOGEN INC0001179110-14-011832
SEC(opens sec.gov)
Feb 274
IMMUNOGEN INC0001179110-14-003781
SEC(opens sec.gov)
Feb 244
IMMUNOGEN INC0001179110-14-003416
SEC(opens sec.gov)
Jan 234
IMMUNOGEN INC0001179110-14-001274
SEC(opens sec.gov)

Companies

Address

C/O PRELUDE THERAPEUTICS INCORPORATED 175 INNOVATION BOULEVARD

WILMINGTON, DE, 19805